DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Electroceuticals/Bioelectric Medicine Market By Product (Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Implants), By Application (Arrhythmia, Pain Management, Hearing Loss), By Type, By End-use, And Segment Forecasts 2014 - 2025" report to their offering.
The global electroceuticals/bioelectric medicine market is expected to reach USD 35.5 billion by 2025
Rising geriatric population is the major factor that is expected to propel growth during the forecast period. Aging population is prone to various diseases such as cardiac arrhythmias, Parkinson's disease, Alzheimer's disease, epilepsy, and depression. There are various advanced electroceuticals including implantable cardioverter defibrillators, cochlear implants, cardiac pacemakers, and spinal cord stimulators, which can be used for the treatment of these conditions.
Increasing investment in the development of advanced bioelectric medicine is another major factor supporting the growth of the electroceuticals market. For instance, in FY 2016, Medtronic, a leading bioelectric medicine manufacturer, invested around USD 2,224 million in R&D for development of advanced products. Technological advancements in these products propel their adoption in treatment of chronic diseases such as cardiac arrhythmias and Parkinson's disease. The technological advanced electroceuticals provide high reliability and efficiency during treatment.
Some of the major players include Medtronic; St. Jude Medical; Boston Scientific Corporation; Cochlear Ltd.; Sonova; LivaNova PLC; Biotronik; Nevro Corp.; SECOND SIGHT; and electroCore LLC.
Key Topics Covered:
1 Research Methodology
2 Executive Summary
3 Electroceuticals/Bioelectric Medicine Market Variables, Trends & Scope
4 Electroceuticals/Bioelectric Medicine: Product Estimates & Trend Analysis
5 Electroceuticals/Bioelectric Medicine: Type Estimates & Trend Analysis
6 Electroceuticals/Bioelectric Medicine: Application Estimates & Trend Analysis
7 Electroceuticals/Bioelectric Medicine: End-use Estimates & Trend Analysis
8 Electroceuticals/Bioelectric Medicine: Regional Estimates & Trend Analysis, by Product, Type, Application, End Use
9 Competitive Landscape
- St. Jude Medical, Inc.
- Boston Scientific Corporation
- Cochlear Ltd
- LivaNova PLC
- Nevro Corp.
- Second Sight
- electroCore LLC.
For more information about this report visit https://www.researchandmarkets.com/research/qww2dr/electroceuticalsb